BALTIMORE, April 13, 2022 /PRNewswire/ — Today, Maryland Proton Treatment Center (MPTC), a state-of-the-art radiation oncology center based in Baltimore, Marylandannounced that it is now designated a Center of Excellence in Proton Therapy.
“This designation is based on qualifications that make MPTC an exceptional place and a world leader in the field of advanced radiation therapy. For more than six years, we have continued to exceed industry standards in the areas of radiation therapy. expertise, technology, patient experience, research and diversity,” says Leigh T. Howe, president and CEO of Maryland Proton Treatment Center. “And while the majority of patients who choose MPTC come from DC/Maryland/Virginia region, the experience and expertise of our doctors have attracted patients from all over the world. »
MPTC is the region’s most sought-after proton therapy center due to the unparalleled expertise of its world-renowned physicians and staff. As the first and only proton therapy center in Maryland, MPTC has treated more than 3,500 patients from 31 states across the country and 15 countries around the world. MPTC features a pencil beam scanner, the most advanced form of proton therapy available, along with high quality image guidance ensuring precision treatment for every patient, and it is the only treatment center in the world that offers both proton and thermal therapies in one facility. . MPTC has educated and trained hundreds of proton therapy providers and healthcare professionals in the United States and abroad.
“Our designation as a Center of Excellence in Proton Therapy is based on a number of industry standards, including research. MPTC leads the industry in clinical trials, and our participants are among the most diverse in the country and closely match the demographics of our community,” says Matthew E. WitekMD, MS, Medical Director of Maryland Proton Treatment Center and Associate Professor of Radiation Oncology at University of Maryland School of Medicine. “And because of our dedication to research, we were named #2 in the US for NRG clinical trial accruals and #2 in the world.”
MPTC sets itself apart from other proton treatment centers with its special integrated patient experience which maintains a patient satisfaction average of 4.8 out of 5 and access to support services such as a nutritionist, a the life of the child, a social worker and a concierge team. Experienced doctors at MPTC have successfully treated tumors of the brain, breast, esophagus, eyes, head and neck, liver, lungs, pancreas, prostate, reproductive organs, spine and skin, as well as lymphomas. MPTC also treats patients who have cancer recurrences with reirradiation. These cases represent 20% of MPTC patients and offer hope when other forms of treatment may no longer be an option.
About Maryland Proton Treatment Center
The Maryland Proton Treatment Center is the first healthcare organization to offer proton therapy in the Baltimore/Washington region. On February 23, 2016, MPTC opened its doors to provide a highly advanced and precise form of radiation therapy to adult and pediatric cancer patients that can increase the radiation dose to a tumor while decreasing the dose to surrounding healthy tissue. MPTC is affiliated with the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), an NCI-designated comprehensive cancer center (one of 52 nationwide) and is located in the UM BioPark. The center has treated more than 3,500 patients from surrounding states and around the world. For more information on MPTC, proton therapy, and treatable cancer/disease sites, visit mdproton.com or call 410-369-5200.
SOURCE Maryland Proton Processing Center